YHP-1318

N/A

Report date: 2025/03/07 15:29:12
NME

Base Information

Drug NameYHP-1318
Drug Alias NameYHP1318YHP-1318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitorsPoly (ADP-Ribose) Polymerase 2 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1Poly (ADP-Ribose) Polymerase 2
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A